arrow
S

Silvia Oghina

university of paris-east creteil
H指数:15
被引数:655

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Incidence and Predictors of Appropriate Implantable Cardioverter-Defibrillator Therapy in Light Chain Cardiac Amyloidosis

轻链心脏淀粉样变性患者植入式心律转复除颤器恰当治疗的发病率和预测因素

2026-02-260
PRE
Characteristics and Prognosis of Wild-Type Transthyretin Amyloid Cardiomyopathy Patients Diagnosed Before 65 Years Old

野生型甲状腺素转运蛋白淀粉样变性心肌病在65岁前确诊患者的特征与预后

2025-11-010
OAAI
Diagnostic pathway for cardiac amyloidosis from the healthcare professional’s perspective: results from the French DIAM-ATTR survey

从医疗专业人员角度的心脏淀粉样变性诊断路径:法国DIAM-ATTR调查结果

2025-06-300
OAAI
Wild-type transthyretin cardiac amyloidosis and aortic stenosis: Can carpal tunnel syndrome help distinguish the chicken from the egg?

野生型甲状腺素运载蛋白心脏淀粉样变性和主动脉瓣狭窄: 腕管综合征能帮助区分鸡和蛋吗?

2024-11-280
OA
Improving genetic testing pathways for transthyretin amyloidosis in France: challenges and strategies
2024-10-290
PRE
Prevalence, Characteristics, and Impact on Prognosis of Aortic Stenosis in Patients With Cardiac Amyloidosis

心脏淀粉样变性患者主动脉瓣狭窄的患病率、特征及对预后的影响

2024-07-020
OAAI
Prognostic mortality factors in advanced light chain cardiac amyloidosis: A prospective cohort study
2024-03-052
OA
Comparison of cardiac involvement, extracardiac manifestations and outcomes between homozygote and heterozygote transthyretin p.Val142Ile (V122I) variant in patients with hereditary transthyretin amyloidosis: a cohort study

纯合子和杂合子转甲状腺素蛋白p.Val142Ile (V122I) 变体在遗传性转甲状腺素蛋白淀粉样变性患者中心脏受累、心外表现和预后的比较: 一项队列研究

2023-06-280
PRE